Complete vaccine package contract with providers should be basis of VFC procurement -- Connaught exec.
Executive Summary
FEDERAL VACCINE PROGRAM PAYMENTS TO PROVIDERS FOR COMPLETE SCHEDULE administration should be considered, Connaught VP-Public Policy Christine Grant argued at a National Institute for Allergy & Infectious Diseases workshop on pertussis vaccines June 4 in Washington, D.C. "This would give the authority and responsibility to providers, not government or insurers, to design the most patient- and provider-friendly, cost-effective way to deliver the vaccine schedule in five or six visits," Grant maintained. "Those visits could vary: they could be the kind of brief immunization visits or it could be the full well-child development visits."
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth